Companies similar to KORRO BIO INC (KRRO)
Health Care · NASDAQ
KORRO BIO INC (KRRO)'s closest peers include Alnylam Pharmaceuticals (ALNY), Ionis Pharmaceuticals (IONS), ARROWHEAD PHARMACEUTICALS, INC. (ARWR), INTELLIA THERAPEUTICS INC (NTLA), CRISPR THERAPEUTICS AG (CRSP) and BEAM THERAPEUTICS INC (BEAM). This peer set is drawn from KRRO's enriched company profile and is informational only — not financial advice.
Similar companies
-
Alnylam PharmaceuticalsALNYHealth Care
Alnylam is a global leader in RNA interference therapeutics, pioneering a new class of genetic medicines to treat rare and serious diseases.
$271.37 (as of 2026-07-21) · market cap $36.2B
-
Ionis PharmaceuticalsIONSHealth Care
Pioneer in RNA-targeted antisense medicines with seven commercialized products and expanding late-stage pipeline across rare neurological and cardiometabolic…
$53.39 (as of 2026-07-21) · market cap $8.8B
-
ARROWHEAD PHARMACEUTICALS, INC.ARWRHealth Care
A clinical-stage biotechnology company pioneering RNA interference (RNAi) therapeutics to treat a wide array of genetic and chronic diseases by silencing…
$74.52 (as of 2026-07-21) · market cap $10.4B
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.47 (as of 2026-07-21) · market cap $1.6B
-
CRISPR THERAPEUTICS AGCRSPHealth Care
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and…
$48.15 (as of 2026-07-21) · market cap $4.6B
-
BEAM THERAPEUTICS INCBEAMHealth Care
Beam Therapeutics is developing base editing medicines—a precision genetic cure approach—for serious inherited diseases like sickle cell disease and rare…
$27.29 (as of 2026-07-21) · market cap $2.8B
Not quite? Describe exactly what you want →
Peers are drawn from KRRO's enriched profile (the same similarity signal the chat uses for "companies like KRRO"). See the full profile: KORRO BIO INC (KRRO).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.